Martin Shkreli: Daraprim Has Always Been Affordable

Updated on

Martin Shkreli: Daraprim Has Always Been Affordable
Published on Nov 25, 2015
Nov. 25 — Turing Pharmaceuticals LLC CEO Martin Shkreli discusses the pricing of the company’s pharmaceuticals. He speaks on “Bloomberg Markets.”

Leave a Comment